Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract a [PDF]
, 2004 Endocrine tumours of the gastrointestinal tract and pancreas may present at different disease stages with either hormonal or hormone-related symptoms/syndromes, or without hormonal symptoms. They may occur either sporadically or as part
Eijck, C.H.J. (Casper) van +3 more
core
Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1
Clinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley +1 more source
Sporadic duodenal macrogastrinoma: a rare case report
Acta Medica Lituanica, 2013 Gastrinomas are rare neuroendocrine tumors characterized by the secretion of gastrin, which causes hyperchlorhydria, thereby producing the Zollinger-Ellison syndrome. In most cases this syndrome manifests as severe peptic ulcer disease. We are presenting
Dainius Šimčikas +5 more
doaj +1 more source
Vergleich Gastrinrezeptorszintigraphie mit 111-In-DTPA-D-Glu1-Minigastrin versus Somatostatinrezeptorszintigraphie mit 111-In-DTPA-D-Phe1-Octreotid bei Patienten mit neuroendokrinen Tumoren. [PDF]
, 2006 60 Patienten mit neuroendokrinen Tumoren erhielten sowohl eine Somatostatinrezeptorszintigraphie (SRS) als auch eine Gastrinrezeptorszintigraphie mit (GRS) (51 Karzinoide, 3 Gastrinome, 2 Glukagonome, 1 Insulinom, 3 Paragangliome).
Behr, T.M. (Prof. Dr.), Graß, Julia
core +1 more source
Molecular Oncology, Volume 19, Issue 3, Page 635-658, March 2025.Screening colorectal tumors for glycoproteins linked to disease progression has revealed several potential therapeutic targets. The secretin receptor (SCTR), identified as a marker of poor prognosis and metastasis in colorectal cancer, has been shown to be a key carrier of N‐glycans with sialylated Lewis antigens. These cancer‐specific glycoproteoforms
Sofia Cotton +12 more
wiley +1 more source
Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours [PDF]
, 2016 Overview on primary outcomes and HRQoL results of studies included in systematic review.
Barbara Sperner-Unterweger +6 more
core +2 more sources
Annals of Gastroenterological Surgery, Volume 9, Issue 2, Page 339-346, March 2025.Distribution of Ki‐67 proliferation indices in EUS‐TA versus surgical histological assessment. Abstract Aim Evidence regarding the reliability of endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) for assessing histological proliferation and WHO grading of small (≤20 mm) pancreatic neuroendocrine tumors (PanNETs) is limited.
Yoshihide Nanno +9 more
wiley +1 more source
Zollinger-Ellison Syndrome: A Narrative Review of Clinical Presentation, Pathogenesis, Diagnosis and Modern Management Approaches [PDF]
Journal of Clinical and Diagnostic ResearchZollinger-Ellison Syndrome (ZES) is rare disorder which is caused by gastrin-secreting neuroendocrine tumours known as gastrinomas, primarily located in the duodenum or pancreas.
Jaideep Reddy +4 more
doaj +1 more source
Neuroendocrine Tumors (NETs) : A population-based study of incidence and survival in Girona province, 1994-2004 [PDF]
, 2012 Els tumors neuroendocrins (TNEs) són un grup de neoplàsies poc freqüents i heterogènies i amb un ampli espectre d'agressivitat. Hi ha molt poca informació epidemiològica a nivell mundial, l'objectiu d'aquest estudi ha estat el de reportar-ne les dades a ...
Alsina Maqueda, Maria +3 more
core